Patent classifications
A61N1/37247
Data labeling system and method operative with patient and clinician controller devices disposed in a remote care architecture
A system and method for facilitating remote care management involving a patient having an implantable medical device (IMD). Upon establishing a remote care session between a patient controller device and a clinician programmer, wherein the clinician and the patient are remotely located with respect to each other, input from the patient or the clinician may be received via a user interface control associated with a particular functionality or aspect of the remote care session, including audiovisual (AV) communications, remote therapy programming, and related context. Responsive to the user input, a dialog interface is effectuated at one of the patient controller device and/or the clinician programmer. A user characterization label is received via the dialog interface from the user, wherein the user characterization label is indicative of a subjective assessment of the particular functionality of the remote care session, which may be used in generating user-labeled data pertaining thereto.
INTERACTIVE PLACEMENT OF ANATOMICAL ATLAS STRUCTURES IN PATIENT IMAGES
This disclosure describes systems, devices, and techniques for adjusting an anatomical atlas to patient anatomy. In one example, a system may include processing circuitry configured to generate, for display at a user interface, a representation of an anatomical region of a patient, generate, for display at the user interface, a representation of one or more atlas-defined anatomical structures at a first position over the representation of the anatomical region of the patient, receive a user annotation that defines an adjustment to at least one atlas-defined anatomical structure relative to the representation of the anatomical region of the patient, and adjust, based on the adjustment, the first position of the representation of the one or more atlas-defined anatomical structures to a second position of the representation of the one or more atlas-defined anatomical structures over the representation of the anatomical region of the patient.
LOW PROFILE HEAD-LOCATED NEUROSTIMULATOR
A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
External controller/charger system for an implantable medical device capable of automatically providing data telemetry through a charging coil during a charging session
An external controller/charger system for an implantable medical device is disclosed, in which the external controller/charger system provides automatic switching between telemetry and charging without any manual intervention by the patient. The external controller/charger system includes an external controller which houses a telemetry coil and an external charging coil coupled to the external controller. Normally, a charging session is carried out using the external charging coil, and a telemetry session is carried out using the telemetry coil. However, when a patient requests to carry out telemetry during a charging session, the external charging coil is used instead of the internal telemetry coil.
Monitoring temporary pacing devices
Apparatus and methods for the management and safety monitoring of temporary cardiac pacing devices adapted to monitor a cardiac pacing device, the apparatus comprising; electrical connections with the heart and with the pacing device; a signal acquisition module adapted to acquire via the electrical connections cardiac signals indicative of cardiac operation, pacing impulses emitted by the pacing device, evoked signals emitted from the heart in response to the pacing impulses, and any unidentified noise signals; a processor adapted to receive from the signal acquisition module and to analyse the cardiac and evoked signals, the pacing impulses and any noise signals; a data store, and a display, wherein the processor is adapted to: i. establish a base level operation of the heart and pacing device and to store the associated quality, size and/or timing values of the cardiac and evoked signals and the pacing impulses in the date store; ii, receive instantaneous values of quality, size and/or timing values of the cardiac and evoked signals and the pacing impulses and to cause the display to show these values; iii. compare the instantaneous values against the values in the data store to establish differences therebetween; iv. analyse; a, any noise signal received, b. the instantaneous values received at step ii above, and c. any difference(s) at step iii above in terms of its/their quality, size and timing, and v, raise an alarm in the event a noise signal occurs and/or no evoked signal is received,
System and method for delivering modulated sub-threshold therapy to a patient
A neuromodulation system configured for providing sub-threshold neuromodulation therapy to a patient. The neuromodulation system comprises a neuromodulation lead having at least one electrode configured for being implanted along a spinal cord of a patient, a plurality of electrical terminals configured for being respectively coupled to the at least one electrode, modulation output circuitry configured for delivering sub-threshold modulation energy to active ones of the at least one electrode, and control/processing circuitry configured for selecting a percentage from a plurality of percentages based on a known longitudinal location of the neuromodulation lead relative to the spinal cord, computing an amplitude value as a function of the selected percentage, and controlling the modulation output circuitry to deliver sub-threshold modulation energy to the patient at the computed amplitude value.
SYSTEMS AND METHODS FOR CLINICAL DECISION MAKING FOR A PATIENT RECEIVING A NEUROMODULATION THERAPY BASED ON DEEP LEARNING
Information relevant to making clinical decisions for a patient is identified based on electrical activity records of the patient's brain and electrical activity records of other patients' brains. A deep learning algorithm is applied to an electrical activity record of the patient, i.e., an input record, and to a set of electrical activity records of other patients, i.e., a set of search records, to obtain an input feature vector of the patient and a set of search feature vectors, each including features extracted by the deep learning algorithm. A similarities algorithm is applied to the input feature vector and the set of search feature vectors to identify a subset of search records most like the input record. Clinical information associated with one or more search records in the identified subset of search records is extracted from a database and used to make decisions regarding the patient's neuromodulation therapies.
IMPLANTABLE MEDICAL DEVICE WITH SYSTEM INTEGRITY DETERMINATION FOR EXPEDITED PATIENT DISCHARGE
An implantable medical device (IMD) performs, within a first predetermined time following an implantation, a first device test sequence over an evaluation period. The device test sequence includes at least two of: detecting an impedance for at least one electrical path having at least one electrode, and comparing the impedance to a first predetermined impedance threshold to determine a connection status of the IMD; comparing, over an electrogram (EGM) test period, at least one EGM event of the patient against a first predetermined EGM event threshold; determining a first pacing capture threshold of the IMD; and detecting at least one clinical or patient-specific physiologic metric, and comparing the physiologic metric to a first predetermined physiologic metric threshold. The IMD transmits within a second predetermined time a status signal to an external device indicating a status of at least one of the diagnostic tests in the first device test sequence.
SYSTEMS AND METHODS TO LOCATE AN IMPLANTABLE STIMULATOR DEVICE INSIDE A SUBJECT
Implementations provide a method that includes: placing a controller device over a surface region of the patient where the implantable wireless stimulation device has been implanted; configuring the controller device to (i) monitor a return loss representing electrical power reflected from the implantable wireless stimulation device to the controller device; (ii) compute a first path loss metric based on a first monitored return loss when the controller device is place over a first location within the surface region; (iii) compute a second path loss metric based on a second monitored return loss when the controller device is over a second location within the surface region; and (iv) generate a feedback to an operator to indicate whether the second path loss is smaller than the first path loss such that the controller device is placed at a location with more electrical energy non-inductively transferred to the implantable wireless stimulation device.
System and method for mapping arbitrary electric fields to pre-existing lead electrodes
A system for a neurostimulator coupled to electrodes, and a method of providing therapy to a patient using the electrodes implanted within the patient. A target multipole relative to the electrodes is defined. The target multipole is emulated by defining an initial electrical current distribution for the electrodes, such that a first set of active electrodes respectively has electrical current values of a first polarity. Each of the electrical current values of the first polarity is compared to a first threshold value, and at least one of the electrodes in the first active electrode set is zeroed-out based on the comparison. The electrical current value of each of the zeroed-out electrode(s) is redistributed to remaining ones of the electrodes to define a new electrical current distribution for the electrodes. Electrical current is conveyed to the electrodes in accordance with the new electrical current distribution, thereby providing the therapy.